226 related articles for article (PubMed ID: 21691114)
1. Targeting nuclear bile acid receptors for liver disease.
Trauner M; Baghdasaryan A; Claudel T; Fickert P; Halilbasic E; Moustafa T; Zollner G
Dig Dis; 2011; 29(1):98-102. PubMed ID: 21691114
[TBL] [Abstract][Full Text] [Related]
2. Bile acid transporters and regulatory nuclear receptors in the liver and beyond.
Halilbasic E; Claudel T; Trauner M
J Hepatol; 2013 Jan; 58(1):155-68. PubMed ID: 22885388
[TBL] [Abstract][Full Text] [Related]
3. Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease.
Claudel T; Zollner G; Wagner M; Trauner M
Biochim Biophys Acta; 2011 Aug; 1812(8):867-78. PubMed ID: 21194565
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptors in acute and chronic cholestasis.
Gonzalez-Sanchez E; Firrincieli D; Housset C; Chignard N
Dig Dis; 2015; 33(3):357-66. PubMed ID: 26045270
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-210 Promotes Bile Acid-Induced Cholestatic Liver Injury by Targeting Mixed-Lineage Leukemia-4 Methyltransferase in Mice.
Kim YC; Jung H; Seok S; Zhang Y; Ma J; Li T; Kemper B; Kemper JK
Hepatology; 2020 Jun; 71(6):2118-2134. PubMed ID: 31549733
[TBL] [Abstract][Full Text] [Related]
6. Molecular determinants of gastrointestinal and liver cancers: role of bile acid activated nuclear receptors.
Renga B; Mencarelli A; Cipriani S; Distrutti E
Curr Top Med Chem; 2012; 12(6):625-36. PubMed ID: 22242858
[TBL] [Abstract][Full Text] [Related]
7. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
[TBL] [Abstract][Full Text] [Related]
8. Bile acids as regulators of hepatic lipid and glucose metabolism.
Trauner M; Claudel T; Fickert P; Moustafa T; Wagner M
Dig Dis; 2010; 28(1):220-4. PubMed ID: 20460915
[TBL] [Abstract][Full Text] [Related]
9. Nuclear receptors as therapeutic targets in cholestatic liver diseases.
Zollner G; Trauner M
Br J Pharmacol; 2009 Jan; 156(1):7-27. PubMed ID: 19133988
[TBL] [Abstract][Full Text] [Related]
10. Nuclear receptors in bile acid metabolism.
Li T; Chiang JY
Drug Metab Rev; 2013 Feb; 45(1):145-55. PubMed ID: 23330546
[TBL] [Abstract][Full Text] [Related]
11. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology.
Fuchs CD; Trauner M
Nat Rev Gastroenterol Hepatol; 2022 Jul; 19(7):432-450. PubMed ID: 35165436
[TBL] [Abstract][Full Text] [Related]
12. Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of Lipid Metabolism.
Kumari A; Pal Pathak D; Asthana S
Int J Biol Sci; 2020; 16(13):2308-2322. PubMed ID: 32760200
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation.
Gabbia D; Pozzo L; Zigiotto G; Roverso M; Sacchi D; Dalla Pozza A; Carrara M; Bogialli S; Floreani A; Guido M; De Martin S
PLoS One; 2018; 13(9):e0204336. PubMed ID: 30252871
[TBL] [Abstract][Full Text] [Related]
14. β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis.
Thompson MD; Moghe A; Cornuet P; Marino R; Tian J; Wang P; Ma X; Abrams M; Locker J; Monga SP; Nejak-Bowen K
Hepatology; 2018 Mar; 67(3):955-971. PubMed ID: 28714273
[TBL] [Abstract][Full Text] [Related]
15. Colon cancer checks in when bile acids check out: the bile acid-nuclear receptor axis in colon cancer.
Tang Q; Evans RM
Essays Biochem; 2021 Dec; 65(6):1015-1024. PubMed ID: 34414429
[TBL] [Abstract][Full Text] [Related]
16. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.
Vanwijngaerden YM; Wauters J; Langouche L; Vander Perre S; Liddle C; Coulter S; Vanderborght S; Roskams T; Wilmer A; Van den Berghe G; Mesotten D
Hepatology; 2011 Nov; 54(5):1741-52. PubMed ID: 21800341
[TBL] [Abstract][Full Text] [Related]
17. Bile-ology: from bench to bedside.
Jin LH; Fang ZP; Fan MJ; Huang WD
J Zhejiang Univ Sci B; 2019 May; 20(5):414-427. PubMed ID: 31090267
[TBL] [Abstract][Full Text] [Related]
18. Essential role of nuclear receptors for the evaluation of the benefits of bioactive herbal extracts on liver function.
Wang F; Wu Y; Xie X; Sun J; Chen W
Biomed Pharmacother; 2018 Mar; 99():798-809. PubMed ID: 29710478
[TBL] [Abstract][Full Text] [Related]
19. Bridging cell surface receptor with nuclear receptors in control of bile acid homeostasis.
Li S; Ni A; Feng GS
Acta Pharmacol Sin; 2015 Jan; 36(1):113-8. PubMed ID: 25500873
[TBL] [Abstract][Full Text] [Related]
20. Novel therapeutic targets for cholestatic and fatty liver disease.
Trauner M; Fuchs CD
Gut; 2022 Jan; 71(1):194-209. PubMed ID: 34615727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
